Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2018 1
2019 1
2020 1
2021 9
2022 9
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
External quality assessment scheme for HbA1c assays in Thailand: A 5-year experience.
Suparak S, Pratumvinit B, Ngueanchanthong K, Unpol P, Thanomsakyuth A, Setthaudom C, Kunakorn M, Rojanawiwat A, Uppapong B. Suparak S, et al. Among authors: setthaudom c. Pract Lab Med. 2022 Jun 27;31:e00288. doi: 10.1016/j.plabm.2022.e00288. eCollection 2022 Aug. Pract Lab Med. 2022. PMID: 35814312 Free PMC article.
Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients.
Seree-Aphinan C, Ratanapokasatit Y, Suchonwanit P, Rattanakaemakorn P, O-Charoen P, Pisitkun P, Suangtamai T, Setthaudom C, Chirasuthat S, Chanprapaph K. Seree-Aphinan C, et al. Among authors: setthaudom c. Front Immunol. 2023 Mar 15;14:1138765. doi: 10.3389/fimmu.2023.1138765. eCollection 2023. Front Immunol. 2023. PMID: 37006291 Free PMC article.
CoronaVac induces lower neutralising activity against variants of concern than natural infection.
Vacharathit V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, Laopanupong T, Ludowyke N, Phuphuakrat A, Setthaudom C, Ekronarongchai S, Srichatrapimuk S, Wongsirisin P, Sangrajrang S, Imsuwansri T, Kirdlarp S, Nualkaew S, Sensorn I, Sawaengdee W, Wichukchinda N, Sungkanuparph S, Chantratita W, Kunakorn M, Rojanamatin J, Hongeng S, Thitithanyanont A. Vacharathit V, et al. Among authors: setthaudom c. Lancet Infect Dis. 2021 Oct;21(10):1352-1354. doi: 10.1016/S1473-3099(21)00568-5. Epub 2021 Aug 26. Lancet Infect Dis. 2021. PMID: 34454652 Free PMC article. No abstract available.
Risk-benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study.
Seree-Aphinan C, Suchonwanit P, Rattanakaemakorn P, Pomsoong C, Ratanapokasatit Y, Setthaudom C, Suangtamai T, Chanprapaph K; COVIDVAC-DERM study group. Seree-Aphinan C, et al. Among authors: setthaudom c. J Eur Acad Dermatol Venereol. 2023 May;37(5):e572-e575. doi: 10.1111/jdv.18890. Epub 2023 Jan 31. J Eur Acad Dermatol Venereol. 2023. PMID: 36662625 No abstract available.
Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers.
Watcharananan SP, Jaru-Ampornpan P, Sahawongcharoen S, Naitook N, Himananto O, Jongkaewwattana A, Setthaudom C, Rattanasiri S, Phuphuakrat A, Thakkinstian A, Mavichak V; Praram 9-BIOTEC-Ramathibodi COVID-19 Vaccine Study Group. Watcharananan SP, et al. Among authors: setthaudom c. Am J Transplant. 2022 May;22(5):1459-1466. doi: 10.1111/ajt.16966. Epub 2022 Feb 12. Am J Transplant. 2022. PMID: 35090091 Free article.
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J, Setthaudom C, Kitpermkiat R, Kiertiburanakul S, Malathum K, Assanatham M, Nongnuch A, Phuphuakrat A, Chaumdee P, Janphram C, Thotsiri S, Chuengsaman P, Boongird S. Bruminhent J, et al. Among authors: setthaudom c. Sci Rep. 2022 Mar 4;12(1):3587. doi: 10.1038/s41598-022-07574-w. Sci Rep. 2022. PMID: 35246578 Free PMC article.
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Setthaudom C, Bruminhent J. Boongird S, et al. Among authors: setthaudom c. Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34419552 Free PMC article. No abstract available.
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).
Boongird S, Setthaudom C, Kitpermkiat R, Prasongtanakij S, Srisala S, Chuengsaman P, Nongnuch A, Assanatham M, Kiertiburanakul S, Malathum K, Phuphuakrat A, Bruminhent J. Boongird S, et al. Among authors: setthaudom c. Vaccines (Basel). 2022 Jul 1;10(7):1064. doi: 10.3390/vaccines10071064. Vaccines (Basel). 2022. PMID: 35891228 Free PMC article.
22 results